{"id":"https://openalex.org/W2772045458","doi":"https://doi.org/10.22038/ijp.2017.18557.1516","title":"Comparative Study on the Effect of Risperidone and its Combination with Naltrexone in Pediatric Patients with Autistic Spectrum Disorders: A Clinical Trial Study","display_name":"Comparative Study on the Effect of Risperidone and its Combination with Naltrexone in Pediatric Patients with Autistic Spectrum Disorders: A Clinical Trial Study","publication_year":2017,"publication_date":"2017-12-01","ids":{"openalex":"https://openalex.org/W2772045458","doi":"https://doi.org/10.22038/ijp.2017.18557.1516","mag":"2772045458"},"language":"en","primary_location":{"id":"pmh:oai:doaj.org/article:d04767c9713140c38d6ca49989a76af3","doi":"https://doi.org/10.22038/ijp.2017.18557.1516","is_oa":true,"landing_page_url":"https://doaj.org/article/d04767c9713140c38d6ca49989a76af3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pediatrics, Vol 5, Iss 12, Pp 6375-6382 (2017)","raw_type":"article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["doaj"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doaj.org/article/d04767c9713140c38d6ca49989a76af3","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058653228","display_name":"Fatemeh Moharreri","orcid":"https://orcid.org/0000-0003-3381-1443","observed_orcids":["https://orcid.org/0000-0003-3381-1443"]},"institutions":[{"id":"https://openalex.org/I165560825","display_name":"Mashhad University of Medical Sciences","ror":"https://ror.org/04sfka033","country_code":"IR","type":"education","lineage":["https://openalex.org/I165560825"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Fatemeh Moharreri","raw_affiliation_strings":["Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran","institution_ids":["https://openalex.org/I165560825"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067330770","display_name":"Ebrahim Abdollahian","orcid":"https://orcid.org/0000-0002-7352-7175","observed_orcids":["https://orcid.org/0000-0002-7352-7175"]},"institutions":[{"id":"https://openalex.org/I165560825","display_name":"Mashhad University of Medical Sciences","ror":"https://ror.org/04sfka033","country_code":"IR","type":"education","lineage":["https://openalex.org/I165560825"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Ebrahim Abdollahian","raw_affiliation_strings":["Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran","institution_ids":["https://openalex.org/I165560825"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037841586","display_name":"Seyedeh Azam Hosseini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165560825","display_name":"Mashhad University of Medical Sciences","ror":"https://ror.org/04sfka033","country_code":"IR","type":"education","lineage":["https://openalex.org/I165560825"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Seyedeh Azam Hosseini","raw_affiliation_strings":["Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran","institution_ids":["https://openalex.org/I165560825"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041259248","display_name":"Mansoureh Mirzadeh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165560825","display_name":"Mashhad University of Medical Sciences","ror":"https://ror.org/04sfka033","country_code":"IR","type":"education","lineage":["https://openalex.org/I165560825"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Mansoureh Mirzadeh","raw_affiliation_strings":["Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran","institution_ids":["https://openalex.org/I165560825"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I165560825"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.18117229,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10106","display_name":"Autism Spectrum Disorder Research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10106","display_name":"Autism Spectrum Disorder Research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13393","display_name":"Child Nutrition and Feeding Issues","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.8450000286102295},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":1.0},{"id":"https://openalex.org/keywords/autism-spectrum-disorder","display_name":"autism spectrum disorder","score":0.8629999756813049},{"id":"https://openalex.org/keywords/children-with-autism","display_name":"children with autism","score":0.9340000152587891},{"id":"https://openalex.org/keywords/combination-pharmacotherapy","display_name":"combination pharmacotherapy","score":0.7129999995231628},{"id":"https://openalex.org/keywords/behavioral-symptoms","display_name":"behavioral symptoms","score":0.7210000157356262},{"id":"https://openalex.org/keywords/childhood-autism-rating-scale","display_name":"Childhood Autism Rating Scale","score":0.9179999828338623},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.8180000185966492},{"id":"https://openalex.org/keywords/crossover-design","display_name":"crossover design","score":0.32600000500679016}],"concepts":[{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.8492382764816284},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.8009207844734192},{"id":"https://openalex.org/C3020215106","wikidata":"https://www.wikidata.org/wiki/Q1436063","display_name":"Autistic spectrum","level":3,"score":0.6685707569122314},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5138726234436035},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.46097105741500854},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3994629383087158},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.38375091552734375},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.3772921860218048},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2360379993915558},{"id":"https://openalex.org/C205778803","wikidata":"https://www.wikidata.org/wiki/Q38404","display_name":"Autism","level":2,"score":0.23570814728736877},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.15961024165153503},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.07950624823570251},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:doaj.org/article:d04767c9713140c38d6ca49989a76af3","doi":"https://doi.org/10.22038/ijp.2017.18557.1516","is_oa":true,"landing_page_url":"https://doaj.org/article/d04767c9713140c38d6ca49989a76af3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pediatrics, Vol 5, Iss 12, Pp 6375-6382 (2017)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:doaj.org/article:d04767c9713140c38d6ca49989a76af3","doi":"https://doi.org/10.22038/ijp.2017.18557.1516","is_oa":true,"landing_page_url":"https://doaj.org/article/d04767c9713140c38d6ca49989a76af3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pediatrics, Vol 5, Iss 12, Pp 6375-6382 (2017)","raw_type":"article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1563445983","https://openalex.org/W1992118391","https://openalex.org/W2004679057","https://openalex.org/W2010893354","https://openalex.org/W2024408980","https://openalex.org/W2026473386","https://openalex.org/W2041308542","https://openalex.org/W2059352185","https://openalex.org/W2083952496","https://openalex.org/W2093418477","https://openalex.org/W2095466287","https://openalex.org/W2102742082","https://openalex.org/W2134810756","https://openalex.org/W2140372895","https://openalex.org/W2153868538","https://openalex.org/W2158206218","https://openalex.org/W2218458662","https://openalex.org/W2614349964"],"related_works":["https://openalex.org/W2889268835","https://openalex.org/W2093418477","https://openalex.org/W1537251746","https://openalex.org/W1993459964","https://openalex.org/W139972889","https://openalex.org/W2068805947","https://openalex.org/W2053883300","https://openalex.org/W2092708362","https://openalex.org/W2097918000","https://openalex.org/W2788740997"],"abstract_inverted_index":{"Background":[0],"Autistic":[1],"spectrum":[2],"disorder":[3],"(ASD)":[4],"refers":[5],"to":[6,59,115,164,174,212],"a":[7,124,218],"syndrome":[8],"associated":[9],"with":[10,52,70,106],"persistent":[11],"impairments":[12],"in":[13,72,89,167,178,196,227],"communication":[14],"skills,":[15],"social":[16],"interactions,":[17],"and":[18,26,31,38,67,80,92,99,108,118,206],"so":[19],"forth.":[20],"Given":[21],"the":[22,61,144,159,176,185,191,197,213,222],"approval":[23],"of":[24,64,127,155,161,184,200,224],"risperidone":[25,66,107,119],"naltrexone":[27,71,215],"by":[28],"U.S.":[29],"Food":[30],"Drug":[32],"Administration":[33],"(FDA)":[34],"for":[35,120,134,221],"ASD":[36],"cases":[37,157],"extant":[39],"controversy":[40],"concerning":[41],"their":[42],"pertained":[43],"side":[44,165],"effects,":[45],"this":[46,90],"double-blind,":[47],"placebo-controlled,":[48],"crossover":[49],"clinical":[50],"trial":[51,177],"2-treatment,":[53],"2-sequence,":[54],"2-period":[55],"design":[56],"was":[57,113,188,194],"intended":[58],"evaluate":[60],"behavioral":[62,139,225],"effectiveness":[63],"individual":[65,192],"its":[68],"combination":[69],"autistic":[73,85],"children":[74,86],"aged":[75],"4-12":[76],"years":[77],"old.":[78],"Materials":[79],"Methods":[81],"A":[82,98],"total":[83,198],"of30":[84],"were":[87,131,141,152],"recruited":[88],"study,":[91],"then":[93],"equally":[94],"assigned":[95],"into":[96],"groups":[97],"B.":[100,180],"The":[101,138,181],"first":[102],"group":[103,111,168,179],"underwent":[104],"co-treatment":[105],"naltrexone,":[109],"while":[110,170],"B":[112],"instructed":[114],"use":[116],"placebo":[117],"8":[121,136],"weeks.":[122,137],"After":[123],"washout":[125],"period":[126],"two":[128],"weeks,":[129],"treatments":[130],"crossed":[132],"over":[133],"another":[135],"changes":[140],"assessed":[142],"applying":[143],"childhood":[145],"autism":[146,228],"rating":[147],"scale":[148],"(CARS).":[149],"Results":[150],"There":[151],"five":[153],"out":[154],"30":[156],"at":[158],"risk":[160],"drop-out":[162],"due":[163],"effect":[166,182],"A,":[169],"only":[171],"three":[172],"failed":[173],"complete":[175],"size":[183],"combined":[186],"treatment":[187],"greater":[189],"than":[190],"which":[193],"manifest":[195],"score":[199],"CARS,":[201],"improved":[202],"4-week":[203],"listening":[204],"response,":[205],"8-week":[207],"general":[208],"impressions.":[209],"Conclusion":[210],"According":[211],"results,":[214],"can":[216],"be":[217],"promising":[219],"candidate":[220],"management":[223],"symptoms":[226],"children.":[229]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":11}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2017-12-22T00:00:00"}